Recital 5, Directive (EU) 1998/44

In forcesince 6 Jul 1998cited 4×

Whereas differences exist in the legal protection of biotechnological inventions offered by the laws and practices of the different Member States; whereas such differences could create barriers to trade and hence impede the proper functioning of the internal market;

  • Judgment of the Court (Grand Chamber) of 18 October 2011. Oliver Brüstle v Greenpeace eV.Decision

    That conclusion is supported by the object and the aim of the Directive. It follows from recitals 3 and 5 to 7 in the preamble to the Directive that it seeks, by a harmonisation of the rules for the legal protection of biotechnological …

    18 Oct 2011 · 62010CJ0034

  • Judgment of the Court (Grand Chamber) of 6 July 2010. Monsanto Technology LLC v Cefetra BV and Others.Decision

    In order to answer the second question, it is appropriate to note that, in recitals 3 and 5 to 7 in the preamble to the Directive, the Community legislature states that: effective and harmonised protection throughout the Member States is …

    6 Jul 2010 · 62008CJ0428

  • Opinion of Advocate General Bot delivered on 11 December 2012. Kingdom of Spain and Italian Republic v Council of the European Union.Decision

    Next, it is undisputed that rendering intellectual property uniform plays an important role with regard to observance of the fundamental principles of the internal market. It is also clear that when adopting acts relating to intellectual …

    11 Dec 2012 · 62011CC0274

  • Opinion of Advocate General Cruz Villalón delivered on 17 July 2014. International Stem Cell Corporation v Comptroller General of Patents, DDecision

    Recitals 5, 16, 20, 21, 36 to 39, and 42 of the Directive read as follows: … differences exist in the legal protection of biotechnological inventions offered by the laws and practices of the different Member States; … such differences …

    17 Jul 2014 · 62013CC0364